Your browser doesn't support javascript.
loading
Peptide Super-Agonist Enhances T-Cell Responses to Melanoma.
Galloway, Sarah A E; Dolton, Garry; Attaf, Meriem; Wall, Aaron; Fuller, Anna; Rius, Cristina; Bianchi, Valentina; Theaker, Sarah; Lloyd, Angharad; Caillaud, Marine E; Svane, Inge Marie; Donia, Marco; Cole, David K; Szomolay, Barbara; Rizkallah, Pierre; Sewell, Andrew K.
Afiliação
  • Galloway SAE; T-Cell Modulation Group, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Dolton G; T-Cell Modulation Group, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Attaf M; T-Cell Modulation Group, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Wall A; T-Cell Modulation Group, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Fuller A; T-Cell Modulation Group, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Rius C; T-Cell Modulation Group, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Bianchi V; T-Cell Modulation Group, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Theaker S; T-Cell Modulation Group, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Lloyd A; T-Cell Modulation Group, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Caillaud ME; Immunocore LTD, Oxford, United Kingdom.
  • Svane IM; T-Cell Modulation Group, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Donia M; Department of Hematology and Oncology, Center for Cancer Immune Therapy, Herlev Hospital, University of Copenhagen, Herlev, Denmark.
  • Cole DK; Department of Hematology and Oncology, Center for Cancer Immune Therapy, Herlev Hospital, University of Copenhagen, Herlev, Denmark.
  • Szomolay B; T-Cell Modulation Group, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Rizkallah P; Immunocore LTD, Oxford, United Kingdom.
  • Sewell AK; Systems Immunity Research Institute, Cardiff University School of Medicine, Cardiff, United Kingdom.
Front Immunol ; 10: 319, 2019.
Article em En | MEDLINE | ID: mdl-30930889
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Linfócitos T Citotóxicos / Linfócitos T CD8-Positivos / Melanoma Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Linfócitos T Citotóxicos / Linfócitos T CD8-Positivos / Melanoma Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Suíça